Laval University
Also known as: Anne-Sophie Morisset | Centre de Recheche du Centre Hospitalier Université Laval | Centre de recherche CERVO | Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec | Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | Centre de recherche du CHU de Quebec | Centre de recherche du CHU de Québec - Université Laval | Centre de Recherche du CHUL (CHUQ), Quebec | Centre Hospitalier de l'Universite Laval | Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale | CHU de Québec - Université Laval | CHU de Québec-Université Laval | Chu de Quebec | CHU de Quebec | CHU de Québec | CHU de Québec-Univeristé Laval | CHU de Quebec-Universite Laval | CHU de Québec - Université Laval | CHU de Québec-Université Laval | CHU de Québec - Université Laval (CHUQ-UL) | CHU de Québec-Université Laval, Laval University | CHUL Research Center | CHUL Research Center Director | CHUL Research Director | CHU Quebec | Clinique de Recherche en Traitements Hormonaux, 2785 blvd Laurier - Suite SS5, Quebec, QC, Canada | Clinique de Recherche en Traitements Hormonaux, Quebec | C Minville | CRIUCPQ-UL | Dre Edeltraut Kröger | Faculty of Medicine, Laval University. | François Lellouche | Hopital Laval | Hopital Laval, Quebec | Hospital de la Cite-de-la Sante-de-Laval | INSPQ, CHUQ-CHUL, Laval University | Institue of Nutrition and Functional Food (INAF), Laval University | Institut des Nutraceutiques et Aliments fonctionnels, Quebec | Institut des Nutraceutiques et Aliments fonctionnels, Quebec (Clinical nutrition facilities) | Institut des nutraceutiques et des aliments fonctionnels | Institute of Nutraceutical and Functional Foods (INAF), Laval University | Institute of Nutraceuticals and Functional Foods (INAF), Laval University. | Institute of nutrition and functional foods, Laval University | Institut Universitaire de Cardiologie et de Pneumologie de Quebec | Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) | Institut universitaire de cardiologie et de pneumologie de Québec -ULaval | Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval | Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | Institut universitaire de pneumologie et cardiologue de Québec - ULaval | Instute of Nutrition and Functional Foods, Laval University | IUCPQ | IUCPQ-UL | Laval Hospital Research Center | Laval University | Laval University and Hotel Dieu-de-Quebec | Laval University Hospital Center, Public Health Research Unit | Laval University Hospital Center, Quebec, Canada. | Laval University, Quebec, Qc (Canada) | L'Hopital Laval | Louis-Philippe Boulet | Marc Perron | Nursing Faculty, Laval University | Olivier F. Bertrand | Paul R Fortin | Quebec Heart Institute | Steeve Provencher | Stéphane Bolduc | Universite Laval | Université Laval | Université Laval (CRIUCPQ-ULaval) | University Laval | University of Laval | Véronique Flamand
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1994Last known activity
Nov 3, 2025
Timeline
1660s
- Jan 1, 1663
Laval University— Founded
Drugs by trial phase (182 distinct, 194 trials)
Phase 4 (57 own, 0 via acquisition)
Phase 3 (41 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (46 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Acute Disease
- Anxiety Disorders
- Aortic Valve Stenosis
- Apnea
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Asthma, Exercise-Induced
- Atherosclerosis
- Atrophy
- Birth Weight
- Body Weight
- Bone Diseases
- Bone Diseases, Metabolic
- Breast Neoplasms
- Bronchitis
- Bronchopulmonary Dysplasia
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cardiovascular Diseases
- Cerebral Infarction
- Cognitive Dysfunction
- Communicable Diseases
- Condylomata Acuminata
- Constriction, Pathologic
- Coronary Artery Disease
- Coronary Disease
- Cystic Fibrosis
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diarrhea
- Disease Progression
- Dyspnea
- Eclampsia
- Erectile Dysfunction
- Familial Primary Pulmonary Hypertension
- Fetal Growth Retardation
- Fibrosis
- Flushing
- Glaucoma
- Glaucoma, Open-Angle
- Glioma
- Gonorrhea
- Headache
- Head and Neck Neoplasms
- Heart Septal Defects
- Heart Septal Defects, Atrial
- Hematoma
- Hematoma, Subdural
- Hematoma, Subdural, Chronic
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hot Flashes
- Hypercholesterolemia
- Hyperlipidemias
- Hypertension
- Infarction
- Infections
- Influenza, Human
- Insulin Resistance
- Ischemia
- Kidney Diseases
- Leukemia
- Leukemia, Lymphoid
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Lower Urinary Tract Symptoms
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Mental Disorders
- Metabolic Diseases
- Metabolic Syndrome
- Migraine Disorders
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myocardial Infarction
- Myocardial Ischemia
- Myotonic Dystrophy
- Neoplasms
- Neuroendocrine Tumors
- Neurofibroma
- Neurofibroma, Plexiform
- Neurofibromatoses
- Obesity
- Ocular Hypertension
- Osteoarthritis
- Osteoarthritis, Hip
- Osteoarthritis, Knee
- Osteoporosis
- Ovarian Neoplasms
- Overweight
- Papillomavirus Infections
Recent trials (50)
- NCT07240558CollaboratorPhase 3Nov 3, 2025
- NCT07275060CollaboratorPhase 4Oct 14, 2025
- NCT06943495OfficialPhase 1Aug 15, 2025
- NCT06943495Lead sponsorPhase 1Aug 15, 2025
- NCT06943495Sponsor investigatorPhase 1Aug 15, 2025
- NCT06943495CollaboratorPhase 1Aug 15, 2025
- NCT06884540Lead sponsorN/AJul 15, 2025
- NCT07066176OfficialN/AJul 7, 2025
- NCT07066176Sponsor investigatorN/AJul 7, 2025
- NCT07066176Lead sponsorN/AJul 7, 2025
- NCT06906068CollaboratorN/AJun 2, 2025
- NCT06779149Lead sponsorN/AFeb 28, 2025
- NCT06779149Sponsor investigatorN/AFeb 28, 2025
- NCT06833814OfficialPhase 4Feb 17, 2025
- NCT06833814Sponsor investigatorPhase 4Feb 17, 2025
Details
- Founded
- Quebec City, CA Jan 1, 1663
- Last known activity
- Nov 3, 2025